Logo image of IMRA

BITWISE MARA INCOME STRAT (IMRA) Stock Price, Forecast & Analysis

USA - NYSE Arca - NYSEARCA:IMRA - US0917487078 - ETF

16.9094 USD
-0.49 (-2.82%)
Last: 1/15/2026, 8:04:00 PM
16.79 USD
-0.12 (-0.71%)
After Hours: 1/8/2026, 8:04:00 PM

IMRA Key Statistics, Chart & Performance

Key Statistics
Market Cap443.60M
Revenue(TTM)N/A
Net Income(TTM)N/A
Shares26.23M
Float16.64M
52 Week HighN/A
52 Week LowN/A
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)N/A
PEN/A
Fwd PEN/A
Earnings (Next)03-13
IPO2020-03-12
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
IMRA short term performance overview.The bars show the price performance of IMRA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -20 -40 -60

IMRA long term performance overview.The bars show the price performance of IMRA in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of IMRA is 16.9094 USD. In the past month the price decreased by -6.06%.

BITWISE MARA INCOME STRAT / IMRA Daily stock chart

IMRA Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

IMRA Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 46.97 976.55B
JNJ JOHNSON & JOHNSON 21.15 529.01B
MRK MERCK & CO. INC. 12.6 275.43B
PFE PFIZER INC 8.09 147.20B
BMY BRISTOL-MYERS SQUIBB CO 8.63 115.26B
ZTS ZOETIS INC 19.76 55.21B
RPRX ROYALTY PHARMA PLC- CL A 9.66 22.93B
VTRS VIATRIS INC 5.51 14.79B
ELAN ELANCO ANIMAL HEALTH INC 25.19 12.01B
AXSM AXSOME THERAPEUTICS INC N/A 8.78B
CRNX CRINETICS PHARMACEUTICALS IN N/A 5.35B
BLTE BELITE BIO INC - ADR N/A 5.22B

BITWISE MARA INCOME STRAT / IMRA FAQ

What does IMRA do?

Imara, Inc. is a clinical-stage biopharmaceutical company. The company is headquartered in Brookline, Massachusetts and currently employs 6 full-time employees. The company went IPO on 2020-03-12. The firm is focused on developing and commercializing therapeutics to treat patients suffering from rare inherited genetic disorders of hemoglobin and other serious diseases. Its lead product candidate, tovinontrine (IMR-687), is an oral, highly selective, potent small molecule inhibitor of phosphodiesterase-9 (PDE9). PDE9 selectively degrades cyclic guanosine monophosphate (cGMP), an active signaling molecule. IMR-687 is in Phase IIb clinical development for the treatment of sickle cell disease (SCD) and beta- thalassemia. The company is also focused on initiating a Phase II clinical trial of IMR-687 in heart failure with preserved ejection fraction (HFpEF). The firm is also focused on development of IMR-261, an oral, clinic-ready activator of nuclear factor erythroid 2-related factor 2 (Nrf2).


What is the current price of IMRA stock?

The current stock price of IMRA is 16.9094 USD. The price decreased by -2.82% in the last trading session.


How is the ChartMill rating for BITWISE MARA INCOME STRAT?

IMRA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 0 out of 10.